Fishawack Health, a UK-based global commercialisation partner for the modern life science era, announced on Tuesday that it has named Jonathan (Jon) Koch as its new chief executive officer.
In the new role, Koch is to lead Fishawack Health through its next stage of growth, which is focused on building and retaining talented teams and delivering a complete set of integrated services for customers across the life science industry.
Koch has spent his complete career in the healthcare sector, including around 12 years at Covance as group president of Clinical Development and Commercialisation services. He has served as senior vice president and CEO of Global Dental at Henry Schein.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval